Company: RNAC
Filing Date: 2025-03-13
Form Type: 10-K
Source: 0001453687-25-000060
Chunk: 30

Company: Cartesian Therapeutics, Inc.
Filing Date: 2025-03-13
Form: 10-K
Item: Item 15
Chunk 30
---
Item 15.  Exhibits, Financial Statement Schedules

(a)(1) Financial Statements

See the “Index to Consolidated Financial Statements” on page F-1 below for the list of financial statements filed as part of this report.

(a)(2) Financial Statement Schedules

All financial schedules have been omitted because the required information is either presented in the consolidated financial statements filed as part of this Annual Report on Form 10-K or the notes thereto or is not required.

(a)(3) Exhibits

The following is a list of exhibits filed as part of this Annual Report on Form 10-K.

  Incorporated by ReferenceExhibitNumberExhibit DescriptionFormFile No.ExhibitFilingDate2.1*Agreement and Plan of Merger, dated November 13, 2023, by and among Selecta Biosciences, Inc., Sakura Merger Sub I, Inc., Sakura Merger Sub II, LLC, and Cartesian Therapeutics, Inc.8-K001-377982.111/13/20233.1(a)Restated Certificate of Incorporation of Selecta Biosciences, Inc.8-K001-377983.16/29/20163.1(b)Certificate of Amendment to the Restated Certificate of Incorporation of Selecta Biosciences, Inc., dated June 21, 20228-K001-377983.16/21/20223.1(c)Certificate of Amendment to the Restated Certificate of Incorporation of Selecta Biosciences, Inc., dated November 13, 20238-K001-377983.311/13/20233.1(d)Certificate of Amendment to the Restated Certificate of Incorporation, as amended, of Cartesian Therapeutics, Inc., dated March 28, 2024.8-K001-377983.23/28/20243.2Amended and Restated By-laws of Cartesian Therapeutics, Inc.10-Q001-377983.211/13/20234.1Specimen Stock Certificate evidencing the shares of common stock———Filed herewith4.2Form of Warrant to Purchase Shares of Series E Preferred Stock, dated December 31, 2015, issued by the Registrant to Oxford Finance LLC and Square One Bank, together with a schedule of warrant holdersS-1333-2115554.65/24/20164.3Registration Rights Agreement, dated as of June 11, 2020, by and between